SEEL - Seelos Therapeutics Inc - Stock Price & Catalysts • BiopharmIQ

Enterprise Value

30.25M

Cash

5.843M

Avg Qtr Burn

-10.1M

Short % of Float

4.87%

Insider Ownership

2.82%

Institutional Own.

20.36%

Qtr Updated

06/30/23

Drug Pipeline

Powered by

Only showing assets and stage. See catalyst data with a free or premium account. Unlock more data with a free account.

Drug & Indication	Stage & Event	Catalyst Date
SLS-005 (trehalose) Details Spinocerebellar Ataxia	Phase 2/3 Data readout	Some catalyst date You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details.Sign up now.
SLS-005 (trehalose) Details Amyotrophic lateral sclerosis	Phase 2/3 Data readout	Some catalyst date You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details.Sign up now.
SLS-005 (trehalose) Details Sanfilippo Syndrome	Phase 2/3 Initiation	Some catalyst date You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details.Sign up now.
SLS-002 (intranasal ketamine) Details Major depressive disorder, Acute Suicidal Ideation and Behavior	Phase 2 Update	Some catalyst date You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details.Sign up now.
GFH009 Details Relapsed/refractory acute myeloid leukemia, Acute myeloid leukemia	Phase 1 Data readout	Some catalyst date You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details.Sign up now.
SLS-005 (trehalose) Details Oculopharyngeal Muscular Dystrophy	Failed Discontinued	Some catalyst date You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details.Sign up now.
SLS-006 Details Parkinson's disease	Failed Discontinued	Some catalyst date You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details.Sign up now.